FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Vincent Brandenburg(RWTH Aachen University), Gunnar H. Heine(Agaplesion Markus Hospital), Alexander Schuh
Cited by 87
Related Papers
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
The systemic nature of CKD
|Nature Reviews Nephrology|2017|438
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Lipid management in patients with chronic kidney disease
|Nature Reviews Nephrology|2018|275